When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

Chronic inflammation of the liver is a slow, silent disease that can ultimately lead to scarring, cirrhosis, and even liver ...

Oral presentation to highlight 24-week efficacy and safety dataPoster to feature results of AI-based analyses of liver fibrosis ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Liver fibrosis, a progressive scarring of the liver tissue, represents a major global health burden with limited treatment ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic dysfunction-associated steatotic liver disease, or MASLD. The company said its 18 ...

Liver disease includes any condition that damages your liver. Over time, scar tissue can build up in your liver. Scarring or fibrosis can progress over many years until you develop cirrhosis—the most ...

Congenital hepatic fibrosis is a type of liver disease that is present from birth. It typically affects the function of the bile ducts and the veins that carry blood from the digestive tract to the ...